» Articles » PMID: 38283489

Clostridioides Difficile Infection: A Clinical Review of Pathogenesis, Clinical Considerations, and Treatment Strategies

Abstract

Background: infection (CDI) is a common nosocomial infection. Risk factors for developing CDI include prior hospitalization, being older than 65 years old, antibiotic use, and chronic disease. It is linked with diarrhea and colitis and can vary in severity. It is a major cause of increased morbidity and mortality among hospitalized patients. However, community-acquired CDI is also increasing. Proper diagnosis and determination of severity are crucial for the treatment of CDI. Depending on how severe the CDI is, the patient may endorse different symptoms and physical exam findings. The severity of CDI will determine how aggressively it is treated. Management and treatment: Laboratory studies can be helpful in the diagnosis of CDI. In this regard, common labs include complete blood count, stool assays, and, in certain cases, radiography and endoscopy. Mild-to-moderate colitis is treated with antibiotics, but severe colitis requires a different approach, which may include surgery. Several alternative therapies for CDI exist and have shown promising results. This review will touch upon these therapies, which include fecal transplants, intravenous immunoglobulin, and the use of cholestyramine and tigecycline.

Conclusion: Prevention of CDI can be achieved by proper hygiene, vaccinations, and detecting the infection early. Proper hygiene is indeed noted to be one of the best ways to prevent CDI in the hospital setting. Overprescribing antibiotics is also another huge reason why CDI occurs. Proper prescription of antibiotics can also help reduce the chances of acquiring CDI.

Citing Articles

Inflammatory Markers and Severity in COVID-19 Patients with Clostridioides Difficile Co-Infection: A Retrospective Analysis Including Subgroups with Diabetes, Cancer, and Elderly.

Cerbulescu T, Ignuta F, Rayudu U, Afra M, Rosca O, Vlad A Biomedicines. 2025; 13(1.

PMID: 39857810 PMC: 11761942. DOI: 10.3390/biomedicines13010227.


A Three-Year Analysis of Mortality in Clostridioides difficile Patients in a Tertiary Center.

Gherlan G, Florescu S, Enyedi M, Efrem I, Mitrea A, Clenciu D Cureus. 2024; 16(11):e74291.

PMID: 39717327 PMC: 11666302. DOI: 10.7759/cureus.74291.


The Incidence of Infection in the Post-COVID-19 Era in a Hospital in Northern Greece.

Terzaki M, Kouroupis D, Zarras C, Molyvas D, Michailidou C, Pateinakis P Diseases. 2024; 12(8).

PMID: 39195189 PMC: 11353329. DOI: 10.3390/diseases12080190.


Prevention and cure of murine infection by a Lachnospiraceae strain.

Tejada J, Walters W, Wang Y, Kordahi M, Chassaing B, Pickard J Gut Microbes. 2024; 16(1):2392872.

PMID: 39189608 PMC: 11352710. DOI: 10.1080/19490976.2024.2392872.


Retrospective Analysis of Infection Rates and Outcomes in Hospitalized Patients during the COVID-19 Pandemic: A Unicenter Study in Reus, Spain.

Iftimie S, Lopez-Azcona A, Corchero-Valverde M, Peralta-Vazquez A, Lopez-Cordon L, Garcia-Cervera C J Clin Med. 2024; 13(10).

PMID: 38792341 PMC: 11122305. DOI: 10.3390/jcm13102799.

References
1.
Goorhuis A, Bakker D, Corver J, Debast S, Harmanus C, Notermans D . Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis. 2008; 47(9):1162-70. DOI: 10.1086/592257. View

2.
Surawicz C, Brandt L, Binion D, Ananthakrishnan A, Curry S, Gilligan P . Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108(4):478-98. DOI: 10.1038/ajg.2013.4. View

3.
Carlson T, Gonzales-Luna A, Garey K . Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection. Semin Respir Crit Care Med. 2022; 43(1):28-38. DOI: 10.1055/s-0041-1740973. View

4.
Freeman J, Wilcox M . Antibiotics and Clostridium difficile. Microbes Infect. 1999; 1(5):377-84. DOI: 10.1016/s1286-4579(99)80054-9. View

5.
McDonald L, Gerding D, Johnson S, Bakken J, Carroll K, Coffin S . Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018; 66(7):e1-e48. PMC: 6018983. DOI: 10.1093/cid/cix1085. View